Chemotherapy and hemoglobin F synthesis in sickle cell disease.
Dover
G J
GJ
Department of Pediatrics, Johns Hopkins University Medical School, Baltimore, Maryland 21205.
Charache
S
S
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D001374:Azacitidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007377:Interleukin-3 / Q000627:therapeutic use; D010215:Papio; D011994:Recombinant Proteins / Q000627:therapeutic use
D007377:Interleukin-3; D011994:Recombinant Proteins; D004921:Erythropoietin; D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea